Literature DB >> 20978323

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

S Marchán1, S Pérez-Torras, A Vidal, J Adan, F Mitjans, N Carbó, A Mazo.   

Abstract

BACKGROUND: pancreatic cancer, the fifth leading cause of adult cancer death in Western countries, lacks early detection, and displays significant dissemination ability. Accumulating evidence shows that integrin-mediated cell attachment to the extracellular matrix induces phenotypes and signaling pathways that regulate tumor cell growth and migration.
METHODS: in view of these findings, we examined the role of β3 in pancreatic cancer by generating two stable β3-expressing pancreatic human cell lines and characterizing their behavior in vitro and in vivo.
RESULTS: transduction of β3 selectively augmented the functional membrane αvβ3 integrin levels, as evident from the enhanced adhesion and migration abilities related to active Rho GTPases. No effects on in vitro anchorage-dependent growth, but higher anoikis were detected in β3-overexpressing cells. Moreover, tumors expressing β3 displayed reduced growth. Interestingly, treatment of mice with an αv-blocking antibody inhibited the growth of β3-expressing tumors to a higher extent.
CONCLUSIONS: our results collectively support the hypothesis that αvβ3 integrin has dual actions depending on the cell environment, and provide additional evidence on the role of integrins in pancreatic cancer, which should eventually aid in improving prediction of the effects of therapies addressed to modulate integrin activities in these tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20978323      PMCID: PMC4605807          DOI: 10.3233/ACP-CLO-2010-0538

Source DB:  PubMed          Journal:  Anal Cell Pathol (Amst)        ISSN: 2210-7177            Impact factor:   2.916


  3 in total

1.  Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening.

Authors:  Sandra Pérez-Torras; Anna Vidal-Pla; Rosa Miquel; Vanessa Almendro; Laureano Fernández-Cruz; Salvador Navarro; Joan Maurel; Neus Carbó; Pere Gascón; Adela Mazo
Journal:  Cell Oncol (Dordr)       Date:  2011-06-17       Impact factor: 6.730

2.  Combined targeting of TGF-β1 and integrin β3 impairs lymph node metastasis in a mouse model of non-small-cell lung cancer.

Authors:  Elizabeth Salvo; Saray Garasa; Javier Dotor; Xabier Morales; Rafael Peláez; Peter Altevogt; Ana Rouzaut
Journal:  Mol Cancer       Date:  2014-05-19       Impact factor: 27.401

3.  β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.

Authors:  Rafael Peláez; Xabier Morales; Elizabeth Salvo; Saray Garasa; Carlos Ortiz de Solórzano; Alfredo Martínez; Ignacio M Larrayoz; Ana Rouzaut
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.